Ippolito, E.; Silipigni, S.; Matteucci, P.; Greco, C.; Pantano, F.; D’Auria, G.; Quattrocchi, C.C.; Floreno, B.; Fiore, M.; Gamucci, T.;
et al. Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series. Cancers 2022, 14, 303.
https://doi.org/10.3390/cancers14020303
AMA Style
Ippolito E, Silipigni S, Matteucci P, Greco C, Pantano F, D’Auria G, Quattrocchi CC, Floreno B, Fiore M, Gamucci T,
et al. Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series. Cancers. 2022; 14(2):303.
https://doi.org/10.3390/cancers14020303
Chicago/Turabian Style
Ippolito, Edy, Sonia Silipigni, Paolo Matteucci, Carlo Greco, Francesco Pantano, Giuliana D’Auria, Carlo Cosimo Quattrocchi, Barnaba Floreno, Michele Fiore, Teresa Gamucci,
and et al. 2022. "Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series" Cancers 14, no. 2: 303.
https://doi.org/10.3390/cancers14020303
APA Style
Ippolito, E., Silipigni, S., Matteucci, P., Greco, C., Pantano, F., D’Auria, G., Quattrocchi, C. C., Floreno, B., Fiore, M., Gamucci, T., Tonini, G., & Ramella, S.
(2022). Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series. Cancers, 14(2), 303.
https://doi.org/10.3390/cancers14020303
